株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の糖尿病管理における製品、技術、市場、および機会(2009〜2018年)

Diabetes Management: Products, Technologies, Markets and Opportunities Worldwide 2009-2018

発行 MedMarket Diligence, LLC 商品コード 117126
出版日 ページ情報 英文 280 Pages; 67 Exhibits; 123 Profiles
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
世界の糖尿病管理における製品、技術、市場、および機会(2009〜2018年) Diabetes Management: Products, Technologies, Markets and Opportunities Worldwide 2009-2018
出版日: 2010年07月20日 ページ情報: 英文 280 Pages; 67 Exhibits; 123 Profiles

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当レポートでは、I型およびII型糖尿病の国別動向とともに、血糖モニタリング、インスリンポンプなどのセグメント別糖尿病管理製品概要、技術開発動向、米国、欧州、日本の地域別市場動向、および市場に参入する主な競合企業のプロファイルを交え、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 糖尿病について

  • 糖尿病とは
  • 血糖規制
  • 主な糖尿病のタイプ
  • 診断
  • 現在の治療法
  • 将来的治療アプローチ
  • 治療モニタリング
  • 糖尿病の罹患率と患者数(I型およびII型)
  • 糖尿病による合併症
  • メタボリックシンドローム

第2章 診断およびモニタリングに用いられる製品

  • 血糖モニタリング装置:サプライヤーおよび製品
  • 人工膵臓
  • その他の試験法
  • 糖尿病モニタリングのためのソフトウェアプログラム

第3章 治療に用いられる製品

  • インスリン
  • 経口血糖降下剤

第4章 糖尿病管理の新たなアプローチ

  • 膵臓移植
  • 島細胞移植
  • 幹細胞開発
  • 抗体治療
  • ワクチン
  • 遺伝的アプローチ
  • 新薬
  • 継続的血糖モニタリング

第5章 糖尿病市場

  • 世界市場
  • 製品カテゴリー別市場分析
  • 動向
  • 国別市場

第6章 企業プロファイル

付録

目次
Product Code: D510

Worldwide report on products, trends, competitors and markets for diabetes management.

This report details the worldwide incidence and prevalence by country/region of Type 1 and Type 2 diabetes and details the current and projected market for diagnostic and therapeutic products in the management of diabetes, including anti-diabetic drugs, alternative insulin types, blood glucose monitoring (including continuous monitoring devices), insulin pumps, and other established and emerging products in diabetes management. The report provides an emphasis of detail on the status of development of novel products including noninvasive monitoring, oral/inhaled/other insulin delivery. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor share data are presented for the U.S., individual western European countries (Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom), and Japan. The report profiles active companies including detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, plus additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Products & Technologies Covered:

  • Oral hypoglycemic drugs
  • Insulin by type
  • Blood glucose monitors
  • Lancets
  • Blood sampling devices
  • HbA1c testing
  • Insulin pumps
  • Insulin syringes
  • Inhaled insulin
  • Artificial pancreas
  • Pancreatic transplant
  • Islet cell transplants
  • Stem cell
  • Antibody treatment
  • Vaccines
  • Genetic approaches
  • Novel drugs
  • Continuous glucose monitoring

Table of Contents

EXECUTIVE SUMMARY

  • Some Diabetes Basics
  • A Large and Growing Market
  • A Many-Sided Market
    • Pharmaceuticals for Diabetes
      • Insulin
      • Oral Anti-diabetic Drugs
    • The Pharmaceutical Diabetes Market
    • Insulin Administration Devices
    • Medical Devices for Diabetes
    • Total Diabetes Market
      • Regional Segmentation
  • Market Growth
  • The Diabetes Industry
    • Pharmaceutical Companies
    • Medical Device Companies

Section 1: ABOUT DIABETES

  • 1.1 What is Diabetes?
  • 1.2 Blood Sugar Regulation
    • 1.2.1 Insulin
  • 1.3 Main Types of Diabetes
    • 1.3.1 Type 1 Diabetes
    • 1.3.2 Type 2 Diabetes
    • 1.3.3 Gestational Diabetes
    • 1.3.4 Obesity-Related type 2 Diabetes in Children.
    • 1.3.5 Mature-onset Diabetes of the Young (MODY)
    • 1.3.6 Other Diabetic States
  • 1.4 Diagnosis
    • 1.4.1 Glucose Tests
    • 1.4.2 Official Criteria
    • 1.4.3 Differential Diagnosis
      • 1.4.3.1 Type 1 Diabetes
      • 1.4.3.2 Type 2 Diabetes
  • 1.5 Current Treatment
    • 1.5.1 Type 1 Diabetes
    • 1.5.2 Type 2 Diabetes
    • 1.5.3 Diet
  • 1.6 Future Treatment Approaches
  • 1.7 Treatment Monitoring
    • 1.7.1 Blood Sugar Control
    • 1.7.2 The Diabetes Control and Complications Trial
    • 1.7.3 Glycated haemoglobin (HbA1c)
    • 1.7.4 Fructosamine
  • 1.8 Incidence and Prevalence of Diabetes (Type 1 & Type 2)
    • 1.8.1 Worldwide
    • 1.8.2 USA
    • 1.8.3 Japan
    • 1.8.4 Europe
  • 1.9 Diabetic Complications
    • 1.9.1 Retinopathy
    • 1.9.2 Neuropathy
    • 1.9.3 Nephropathy
  • 1.10 Metabolic Syndrome

Section 2: Products Used in Diagnosis and Monitoring

  • 2.1 Blood Glucose Monitoring Devices: Suppliers and Products
    • 2.1.1 Lancets
    • 2.1.2 Blood Sampling Devices
      • 2.1.2.1 Bayer Diagnostics
      • 2.1.2.2 Becton Dickinson
      • 2.1.2.3 Cell Robotics
      • 2.1.2.4 LifeScan
      • 2.1.2.5 Roche Diagnostics
    • 2.1.3 Blood Glucose Monitors
      • 2.1.3.1 77 Elektronica Kft
      • 2.1.3.2 Abbott Laboratories
      • 2.1.3.3 Acon Laboratories Inc.
      • 2.1.3.4 Apex Biotechnology Corp.
      • 2.1.3.5 Bayer Corporation
      • 2.1.3.6 Becton Dickinson & Co.
      • 2.1.3.7 Belbiosens
      • 2.1.3.8 Cygnus Inc - Animas Corp.
      • 2.1.3.9 Diagnostic Devices Inc.
      • 2.1.3.10 Eumed Biotechnology Co. Ltd.
      • 2.1.3.11 HMD Bio Medical
      • 2.1.3.12 Glucoplus Inc.
      • 2.1.3.13 HemoCue AB
      • 2.1.3.14 Home Diagnostics Inc.
      • 2.1.3.15 Hypoguard
      • 2.1.3.16 LifeScan Inc.
      • 2.1.3.17 Medtronic MiniMed
      • 2.1.3.18 Polymer Technology Systems Inc.
      • 2.1.3.19 QuestStar Medical Inc.
      • 2.1.3.20 Roche
      • 2.1.3.21 TaiDoc Technology Corporation
      • 2.1.3.22 US Diagnostics Inc.
    • 2.1.4 New Developments in Glucose Testing
  • 2.2 ‘Artificial Pancreas'
    • 2.2.1 Medtronic
    • 2.2.2 Roche
    • 2.2.3 Abbott
    • 2.2.4 Novo Nordisk/LifeScan
  • 2.3 Other Testing Approaches
    • 2.3.1 Hemoglobin A1c
      • 2.3.1.1 Hemoglobin A1c Meters
      • 2.3.1.2 Hemoglobin A1c Kits
  • 2.4 Software Programs for Diabetes Monitoring.
    • 2.4.1 Web Software
    • 2.4.2 Commercial Software

Section 3: Products Used in Treatment

  • 3.1 Insulin
    • 3.1.1 History
      • 3.1.1.1 Bovine and Porcine Insulin
      • 3.1.1.2 Humanized Insulin
    • 3.1.2 Companies Supplying Insulin
      • 3.1.2.1 Eli Lilly
      • 3.1.2.2 Aventis
      • 3.1.2.3 Novo Nordisk
      • 3.1.2.4 Some Other Suppliers
    • 3.1.3 Insulin Delivery
      • 3.1.3.1 Syringes
    • 3.1.4 Insulin Syringe Manufacturers
      • 3.1.4.1 Pens
      • 3.1.4.2 Manufacturers of Insulin Pens
      • 3.1.4.3 Injectors
      • 3.1.4.4 Injector Manufacturers
    • 3.1.5 Inhaled insulin
    • 3.1.6 Pfizer/Sanofi-Aventis/Nektar Therapeutics
      • 3.1.6.1 Lilly/Alkermes
      • 3.1.6.2 Novo Nordisk/Aradigm
      • 3.1.6.3 MannKind
    • 3.1.7 Insulin Pumps
      • 3.1.7.1 What is an Insulin Pump?
      • 3.1.7.2 The Infusion Set
      • 3.1.7.3 Candidates for Pump Therapy
    • 3.1.8 Companies Supplying Insulin Pumps
      • 3.1.8.1 Animas Corporation
      • 3.1.8.2 DANA Diabecare
      • 3.1.8.3 Medtronic MiniMed
      • 3.1.8.4 Nipro Diabetes Systems
      • 3.1.8.5 Roche Disetronic
      • 3.1.8.6 Smiths Medical
  • 3.2 Oral Hypoglycaemic Drugs
    • 3.2.1 Sulfonylureas
    • 3.2.2 Biguanides
    • 3.2.3 Alpha-Glucosidase Inhibitor
    • 3.2.4 Thiazolidinediones
    • 3.2.5 Prandial Glucose Regulators
    • 3.2.6 Incretin Mimetics
    • 3.2.7 Amylin Mimetic
    • 3.2.8 New Products Now in R&D

Section 4: Novel Approaches to Diabetes Management

  • 4.1 Pancreas Transplants
  • 4.2 Islet Cell Transplants
    • 4.2.1 Edmonton Protocol
    • 4.2.2 Improving ICT
    • 4.2.3 Living-Donor Islet Cell Transplant
  • 4.3 Stem Cell Developments
    • 4.3.1 ADA Endorsement
    • 4.3.2 Stem Cell Research at EASD 2005
      • 4.3.2.1 Adult Stem Cells
  • 4.4 Antibody Treatment
  • 4.5 Vaccines
    • 4.5.1 Diamyd Medical
    • 4.5.2 DeveloGen
  • 4.6 Genetic Approaches
    • 4.6.1 Genetic Testing
    • 4.6.2 Small-interfering RNA (SiRNA)
  • 4.7 Novel Drugs
    • 4.7.1 DDP-IV Inhibitors
    • 4.7.2 Other Drugs
    • 4.7.3 All-in-one Treatment for Type 2 Diabetes?
  • 4.8 Continuous Glucose Monitoring
    • 4.8.1 Electroenzymatic Sensor
    • 4.8.2 Optical Glucose Sensor
    • 4.8.3 Sensor Based on Carbon Nanotubes

Section 5: The Diabetes Market

  • 5.1 Global Market
    • 5.1.1 Size
    • 5.1.2 Growth
    • 5.1.3 Regional Segmentation
  • 5.2 Market Analysis by Product Category
    • 5.2.1 Monitoring Products
      • 5.2.1.1 Major Suppliers
    • 5.2.2 Insulins and Insulin Delivery Devices
      • 5.2.2.1 Major Suppliers
        • 5.2.2.1.1 Insulin
        • 5.2.2.1.2 Syringes and Other Insulin Administration Devices
        • 5.2.2.1.3 Insulin Pumps
    • 5.2.3 Oral Antidiabetic Drugs
      • 5.2.3.1 Major Suppliers
  • 5.3 Trends
  • 5.4 Main National Markets
    • 5.4.1 Belgium
    • 5.4.2 Denmark
    • 5.4.3 France
    • 5.4.4 Germany
    • 5.4.5 Italy
    • 5.4.6 Japan
    • 5.4.7 Netherlands
    • 5.4.8 Norway
    • 5.4.9 Spain
    • 5.4.10 Sweden
    • 5.4.11 United Kingdom
    • 5.4.12 USA

Section 6: Company Profiles

  • 77 Elektronica
  • Abbott
  • ACON Laboratories
  • Activa Brand Products, Inc.
  • AgaMatrix, Inc.
  • AiMedics Pty Ltd.
  • Alkermes Inc.
  • AmbiMedInc
  • Amylin Animas Corp. (a J&J company)
  • Antares Pharma
  • Apex Biotechnology Ltd
  • Aradigm
  • Arena Pharmaceuticals
  • ARKRAY USA, Inc. (formerly HypoGuard)
  • B Braun
  • Bayer
  • Becton Dickinson
  • Biocon
  • Bioject Medical Technologies Inc.
  • Biovitrum
  • Bristol-Myers Squibb
  • DARA BioSciences, Inc.
  • DexCom, Inc.
  • Diabetes Technologies, Inc. (DTI)
  • Diosynth Biotechnology (a Schering Plough company)
  • Echo Therapeutics
  • Eli Lilly
  • EnGene
  • Eumed Biotechnology Co., Ltd.
  • FivePrime Therapeutics
  • FlexSite Diagnostics
  • GlaxoSmithKline
  • GlucoPlus, Inc.
  • GluMetrics, Inc.
  • HemoCue AB (owned by Quest Diagnostics)
  • HMD BioMedical
  • Home Diagnostics Inc.
  • INJEX - Equidyne Systems (DBA) (Owned by HNS International)
  • InLight Solutions Inc. (formerly Rio Grande Medical Technologies)
  • Integrity Applications Ltd.
  • Johnson & Johnson
  • Kumetrix Inc.
  • Laboratorios Beta
  • Ligand Pharmaceuticals Inc.
  • MannKind Corp.
  • Medtronic
  • Menarini
  • Merck KgaA
  • Metabolex
  • Nektar Therapeutics
  • Nipro Diabetes Systems Inc.
  • Nordisk
  • Novartis Novo
  • Owen Mumford
  • Pfizer
  • Polymer Technology Systems Inc.
  • Prodigy Diabetes Care, LLC
  • Quotient Diagnostics Ltd.
  • Roche
  • Sanofi-Aventis
  • Sanwa Kagaku Kenkyusho Co. Ltd. (a subsidiary of SUZUKEN)
  • SenSys Medical
  • Servier Laboratories
  • Sirna Therapeutics
  • Smiths Medical
  • TaiDoc Technology Corporation
  • Takeda
  • Terumo Medical Corporation
  • Theratechnologies Inc.
  • Tolerx Inc.
  • US Diagnostics Inc.
  • Vaxine Pty Ltd.
  • VeraLight Inc.
  • Verva Pharmaceuticals
  • VivoMedical Inc.
  • Wockhardt Ltd.

Appendix: Company Addresses

Back to Top